Extended-Interval Myeloma Antibody Therapy Safely Omits Repeat Step-Up Dosing in Cohort
A case series of six multiple myeloma patients suggests that extended-interval teclistamab and talquetamab dosing can safely omit repeat step-up ...
A case series of six multiple myeloma patients suggests that extended-interval teclistamab and talquetamab dosing can safely omit repeat step-up ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.